Full text loading...
- ISSN: 1872-213X
- E-ISSN: 2212-2710
-
Inhibitors of Phosphoinositol 3 Kinase and NFκB for the Treatment of Chronic Obstructive Pulmonary Disease
- Source: Recent Patents on Inflammation & Allergy Drug Discovery, Volume 5, Issue 3, Sep 2011, p. 178 - 183
-
- 01 Sep 2011
Abstract
Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized mainly by pulmonary airflow limitation that is not fully reversible. New different pharmacological approaches to decrease inflammation of the airways and consequently disease progression and increase airway obstruction reversibility have been developed. In the present article, we review the new patents on phosphoinositide 3 kinase and NFκb inhibitors for future therapies.
© Bentham Science Publishers